S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Economic and National Security Threats Create Lithium Bonanza (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Economic and National Security Threats Create Lithium Bonanza (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Economic and National Security Threats Create Lithium Bonanza (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Economic and National Security Threats Create Lithium Bonanza (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Economic and National Security Threats Create Lithium Bonanza (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Economic and National Security Threats Create Lithium Bonanza (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Economic and National Security Threats Create Lithium Bonanza (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Economic and National Security Threats Create Lithium Bonanza (Ad)
NASDAQ:MTEM

Molecular Templates - MTEM Earnings Date, Estimates & Call Transcripts

$0.84
-0.03 (-3.45%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.83
$0.89
50-Day Range
$0.77
$1.15
52-Week Range
$0.75
$8.29
Volume
90,179 shs
Average Volume
241,313 shs
Market Capitalization
$47.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Earnings Summary

Upcoming
Earnings Date
Aug. 11Estimated
Actual EPS
(May. 12)
-$0.38 Beat By $0.04
Consensus EPS
(May. 12)
-$0.42
Last Year's Q2 EPS
(5/13/2021)
-$0.51
Skip Charts & View Estimated and Actual Earnings Data

MTEM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MTEM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Molecular Templates Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20222($0.51)($0.39)($0.45)
Q2 20222($0.53)($0.41)($0.47)
Q3 20222($0.56)($0.42)($0.49)
Q4 20222($0.42)($0.32)($0.37)
FY 20228($2.02)($1.54)($1.78)

MTEM Earnings Date and Information

Molecular Templates last issued its earnings results on May 12th, 2022. The biotechnology company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.42) by $0.04. The business earned $8.49 million during the quarter, compared to analyst estimates of $6.88 million. Molecular Templates has generated ($1.38) earnings per share over the last year (($1.38) diluted earnings per share). Earnings for Molecular Templates are expected to decrease in the coming year, from ($1.62) to ($1.71) per share. Molecular Templates has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

Molecular Templates Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/11/2022
(Estimated)
        
5/12/2022Q1 2022($0.42)($0.38)+$0.04($0.38)$6.88 million$8.49 million    
3/28/2022Q4 2021($0.18)($0.18)($0.18)$21.95 million$17.96 million
11/15/2021Q3($0.3780)($0.54)($0.1620)($0.54)$15.69 million$2.38 million
8/12/20216/30/2021($0.30)($0.28)+$0.02($0.28)$30.67 million$15.13 million
5/13/20213/31/2021$0.31($0.51)($0.82)($0.51)$29.66 million$3.22 million
3/17/202112/31/2020($0.42)($0.53)($0.11)($0.49)$9.92 million$3.50 million
11/5/20209/30/2020($0.57)($0.47)+$0.10($0.47)$6.05 million$4.30 million  
8/6/2020Q2 2020($0.37)($0.65)($0.28)($0.62)$5.04 million$6.91 million
5/12/20203/31/2020($0.30)($0.48)($0.18)($0.48)$10.48 million$4.14 million
3/12/202012/31/2019($0.36)($0.41)($0.05)($0.41)$6.20 million$6.20 million
11/12/2019Q3 2019($0.24)($0.43)($0.19)$0.17$6.00 million$3.62 million
8/12/2019Q2 2019($0.23)($0.25)($0.02)($0.25)$6.00 million$5.45 million
5/13/20193/31/2019($0.22)($0.17)+$0.05($0.17)$6.00 million$7.01 million
3/28/2019Q4($0.06)($0.18)($0.12)($0.18)$5.00 million$4.68 million
11/15/2018Q3 2018($0.34)($0.19)+$0.15($0.19)$6.75 million
8/9/2018Q2 2018($0.25)$0.36+$0.61$0.36$1.37 million
5/14/2018Q1 2018($0.25)($0.32)($0.07)($0.32)$0.48 million
3/28/2018Q4 2017($0.20)($0.26)($0.06)($0.26)$0.82 million
11/14/2017Q3 2017($0.62)($0.62)($0.62)$0.65 million
7/31/2017Q2 2017($0.77)$0.22+$0.99$0.02$3.00 million
5/15/2017Q1 2017($0.88)($0.77)+$0.11($0.07)
3/27/2017Q4 2016($0.77)($0.77)($0.99)
11/7/2016Q3 2016($0.99)($0.88)+$0.11($0.88)
8/1/2016Q2 2016($1.21)($1.10)+$0.11($1.10)
5/5/2016Q1 2016($1.65)($1.21)+$0.44($1.21)
3/10/2016Q4 2015($1.21)$6.82+$8.03$4.18$4.51 million$65.87 million
11/2/2015Q3 2015($1.43)($0.99)+$0.44($0.99)$3.69 million$3.70 million
7/30/2015Q2 2015($1.54)($1.32)+$0.22($1.32)$3.70 million$3.68 million
4/30/2015Q1 2015($1.32)($1.87)($0.55)($1.87)$3.44 million$3.68 million
3/3/2015Q4 2014($1.43)($1.54)($0.11)($1.76)$4.34 million$3.68 million
11/3/2014Q3 2014($1.43)($1.65)($0.22)($1.65)$3.82 million$3.70 million  
8/1/2014Q2 2014($1.54)($2.53)($0.99)($3.74)$4.00 million$3.68 million
5/1/2014Q1 2014($0.66)($1.32)($0.66)($1.10)$9.81 million$3.68 million
3/6/2014Q4 2013($1.21)($1.43)($0.22)($1.43)$3.58 million$3.20 million
11/4/2013Q3 2013($1.21)($1.65)($0.44)($2.42)$3.15 million$3.20 million
8/1/2013Q2 2013($0.99)($1.32)($0.33)($0.22)$3.69 million$3.18 million
5/2/2013Q1 2013($0.88)($1.10)($0.22)($0.44)$2.80 million$2.90 million
3/7/2013Q4 2012($1.32)($5.06)($3.74)($9.02)
11/2/2012Q312($0.66)($0.66)$2.29 million$1.80 million
8/2/2012Q2 2012($1.10)($0.44)+$0.66($0.44)
5/3/2012Q1 2012$1.65($1.56)($3.21)$22.14
3/8/2012Q4 2011($1.54)($1.58)($0.04)($1.98)
11/3/2011Q3 2011($1.65)($1.76)($0.11)($2.60)
8/4/2011Q2 2011($1.76)($1.78)($0.02)($1.78)
5/12/2011Q1 2011($1.87)($2.52)($0.65)($2.52)
3/24/2011Q4 2010($2.31)($2.13)+$0.18($2.13)
11/4/2010Q3 2010($2.20)($1.94)+$0.26($1.94)
8/5/2010Q2 2010($1.98)($0.09)+$1.89($0.09)
5/7/2010Q1 2010($1.98)($1.95)+$0.03($1.95)
3/4/2010Q4 2009($1.98)($1.61)+$0.37($1.61)
11/5/2009Q3 2009($4.62)($4.44)+$0.18($4.44)
8/6/2009Q2 2009($3.74)($4.51)($0.77)($4.51)
5/7/2009Q1 2009($3.63)($4.73)($1.10)($4.73)
3/5/2009Q4 2008($3.47)($3.47)($3.47)
11/6/2008Q3 2008($8.58)($5.34)+$3.24($5.34)
8/7/2008Q2 2008($9.24)($7.00)+$2.24($7.00)
5/7/2008Q1 2008($8.84)($8.84)($8.84)
3/6/2008Q4 2007($13.13)($13.13)($13.13)












Molecular Templates Earnings - Frequently Asked Questions

When is Molecular Templates's earnings date?

Molecular Templates has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on MTEM's earnings history.

Did Molecular Templates beat their earnings estimates last quarter?

In the previous quarter, Molecular Templates (NASDAQ:MTEM) reported ($0.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.42) by $0.04. Learn more on analysts' earnings estimate vs. MTEM's actual earnings.

How can I listen to Molecular Templates's earnings conference call?

The conference call for Molecular Templates's latest earnings report can be listened to online. Listen to Conference Call

How can I read Molecular Templates's conference call transcript?

The conference call transcript for Molecular Templates's latest earnings report can be read online. Read Transcript

How much revenue does Molecular Templates generate each year?

Molecular Templates (NASDAQ:MTEM) has a recorded annual revenue of $38.70 million.

How much profit does Molecular Templates generate each year?

Molecular Templates (NASDAQ:MTEM) has a recorded net income of -$83.01 million. MTEM has generated -$1.38 earnings per share over the last four quarters.

What is Molecular Templates's EPS forecast for next year?

Molecular Templates's earnings are expected to decrease from ($1.62) per share to ($1.71) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:MTEM) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.